Research & Development



  衛青低頭看著跟前的曲轅犁,惋惜的看了一眼,在宦官的陪同下出了皇宮。   雲瑯再次嘆口氣道︰“這是大家不多的生財之道,平公,你真的要我說出來?一旦說出來了,我最多退兩萬四千個錢,您可能要退掉的恐怕就不止這點錢了。”全球彩票所有版本   一勺子熱油澆下去,蔥蒜的香味就彌漫了整間屋子。全球彩票app苹果手机下载   郎福心中暗暗有了計較。   看樣子,凡是想要寫點歷史的人,下場都不太好,齊國史官父子兄弟三人中的兩人因為一句“崔杼弒其君”的話被人家斬首了。全球彩票app玩的是骗局吗   平叟雙手插在袖子里,笑眯眯的目送霍去病的馬車離開。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo